How about " SUSTAINED PROFITABILITY beginning in 2018 WITHOUT THE NEED for additional equity capital to fund operations". This is the answer to some of the questions that have been constantly asked by posters here for the last six months. "How is ariad going to fund clinical trials in the future without dilution?". Now, they're saying 3 years is tooooooooo long. Don't this answer Shimoda's tweet yesterday?